Mirabella Financial Services LLP Harmony Biosciences Holdings, Inc. Transaction History

Mirabella Financial Services LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $384,719 - $516,151	8,474 Added 36.68%	31,576 $1.74 Million
Q3 2022 Oct 26, 2022	BUY	$42.06 - $55.45 $971,670 - $1.28 Million	23,102 New	23,102 $1.02 Million
Q1 2022 May 17, 2022	SELL	$33.14 - $51.13 $1.23 Million - $1.9 Million	-37,083 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $1.26 Million - $1.63 Million	37,083 New	37,083 $1.58 Million
Q4 2020 Feb 16, 2021	SELL	$31.74 - $51.34 $451,723 - $730,670	-14,232 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$30.96 - $44.39 $440,622 - $631,758	14,232 New	14,232 $482,000

243

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.04B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.